Pharming Group N.V. ADR (PHAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 90,200 | 72,447 | 106,540 | 97,300 | 93,200 |
| Cost of Goods | 14,500 | 6,644 | 21,077 | 7,100 | 9,000 |
| Gross Profit | 75,700 | 65,803 | 85,463 | 90,200 | 84,200 |
| Operating Expenses | 74,900 | 71,358 | 79,254 | 74,500 | 73,400 |
| Operating Income | 1,300 | -4,911 | 6,286 | 15,800 | 10,800 |
| Other Income | 1,700 | 158 | -1,451 | -3,100 | -3,700 |
| Pre-tax Income | 3,000 | -4,753 | 4,835 | 12,700 | 7,100 |
| Income Tax | 1,400 | 459 | -490 | 5,200 | 2,500 |
| Net Income Continuous | 1,600 | -5,212 | 5,325 | 7,500 | 4,600 |
| Minority Interests | N/A | N/A | -144 | N/A | N/A |
| Net Income | $1,600 | $-5,213 | $5,470 | $7,500 | $4,600 |
| EPS Basic Total Ops | 0.03 | -0.07 | 0.08 | 0.11 | 0.07 |
| EPS Basic Continuous Ops | 0.03 | -0.07 | 0.08 | 0.11 | 0.07 |
| EPS Diluted Total Ops | 0.03 | -0.07 | 0.09 | 0.10 | 0.07 |
| EPS Diluted Continuous Ops | 0.03 | -0.07 | 0.09 | 0.10 | 0.07 |
| EPS Diluted Before Non-Recurring Items | 0.02 | -0.07 | 0.07 | 0.10 | 0.06 |
| EBITDA(a) | $4,338 | $-1,795 | $9,492 | $18,526 | $13,502 |